Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
Artrya Ltd (ASX: AYA) shares were trading at $4.39 as at 3:00pm AEST on August 7, 2026, after recording an increase of approximately 0.23 percent during the session. The stock traded within a narrow intraday range of $4.26 to $4.43, while the broader S&P/ASX …
4DMEDICAL Ltd (ASX: 4DX) shares were trading at $4.315 as at 3:00pm AEST on August 7, 2026, following a session that saw the stock move within a range of $4.12 to $4.62. The company remained within the ASX health care sector, with its daily …
Actinogen Medical Ltd (ASX: ACW) shares were trading at $0.043 as at 3:00pm AEST on August 7, 2026, after recording an increase of approximately 1.19 percent during the session. The stock traded within a narrow intraday range of $0.042 to $0.044, while the broader …
Adalta Ltd (ASX: 1AD) shares were trading at $0.004 as at 3:00pm AEST on August 7, 2026, with trading activity recorded at more than 1.9 million shares during the session. The company remained within the ASX health care sector, where individual stock movements continued …
Adheris Health Ltd (ASX: AHE) shares were trading at $0.016 as at 3:00pm AEST on August 7, 2026, after recording a decline of approximately 5.88 percent during the session. The stock traded at the same recorded day high and low level, while the broader …
At the time of writing on 7 August 2026, 4DMedical (ASX:4DX) share price was AUD 4.26, reflecting an 8.19% decline with a movement of AUD 0.38 on the day. The company’s market activity is being assessed alongside continued commercial expansion of its respiratory imaging …
• Imagion Biosystems received US FDA clearance in June for its investigational new drug application covering the planned Phase 2 trial of the MagSense HER2 imaging agent.
•FY26 revenue from the company's three core verticals is expected at AUD 16.8mn, up 16.5% year on year.
•First-quarter 2026 revenue increased 4% year on year to USD 19.3mn.
Wellnex Life Ltd (ASX:WNX) share price was trading at A$0.11, up 100.00% or A$0.055 on 7 August 2026 at the time of writing. The movement followed the company’s announcement regarding the proposed sale of its Pain Away business to Mentholatum Australasia Pty Ltd, a …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…